Acadia Healthcare Company, Inc. (ACHC) Director Reeve B. Waud Sells 724,694 Shares of Stock

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director Reeve B. Waud sold 724,694 shares of the stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $45.53, for a total value of $32,995,317.82. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Reeve B. Waud also recently made the following trade(s):

  • On Friday, June 9th, Reeve B. Waud sold 50,000 shares of Acadia Healthcare Company stock. The stock was sold at an average price of $45.09, for a total value of $2,254,500.00.

Acadia Healthcare Company, Inc. (ACHC) traded down 1.61% during mid-day trading on Friday, reaching $45.26. The company had a trading volume of 1,512,129 shares. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $62.48. The stock has a market capitalization of $3.97 billion, a price-to-earnings ratio of 263.14 and a beta of 1.11. The company’s 50 day moving average is $43.91 and its 200 day moving average is $40.93.

Acadia Healthcare Company (NASDAQ:ACHC) last announced its earnings results on Tuesday, April 25th. The company reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $679.20 million for the quarter, compared to the consensus estimate of $691.74 million. Acadia Healthcare Company had a return on equity of 8.89% and a net margin of 0.53%. Acadia Healthcare Company’s revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.55 EPS. Equities analysts predict that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

Insider Buying and Selling by Quarter for Acadia Healthcare Company (NASDAQ:ACHC)

TRADEMARK VIOLATION NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Director Reeve B. Waud Sells 724,694 Shares of Stock” was originally reported by sleekmoney and is owned by of sleekmoney. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://sleekmoney.com/acadia-healthcare-company-inc-achc-director-reeve-b-waud-sells-724694-shares-of-stock/1916642.html.

A number of analysts have recently weighed in on the company. Jefferies Group LLC reiterated a “buy” rating on shares of Acadia Healthcare Company in a research report on Friday, May 5th. Citigroup Inc. increased their price target on Acadia Healthcare Company from $43.00 to $52.00 and gave the stock a “buy” rating in a research report on Monday, March 6th. BidaskClub upgraded Acadia Healthcare Company from a “sell” rating to a “hold” rating in a research report on Saturday, June 10th. Cantor Fitzgerald reiterated a “neutral” rating and set a $45.00 price target on shares of Acadia Healthcare Company in a research report on Monday, February 27th. Finally, Mizuho reiterated a “buy” rating and set a $52.00 price target (up from $45.00) on shares of Acadia Healthcare Company in a research report on Monday, February 27th. Five analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $57.82.

Several hedge funds and other institutional investors have recently made changes to their positions in ACHC. Seven Eight Capital LP acquired a new position in shares of Acadia Healthcare Company during the fourth quarter valued at approximately $152,000. Emerald Mutual Fund Advisers Trust acquired a new position in shares of Acadia Healthcare Company during the first quarter valued at approximately $210,000. Paloma Partners Management Co acquired a new position in shares of Acadia Healthcare Company during the first quarter valued at approximately $217,000. Pacad Investment Ltd. acquired a new position in shares of Acadia Healthcare Company during the fourth quarter valued at approximately $166,000. Finally, M&T Bank Corp acquired a new position in shares of Acadia Healthcare Company during the first quarter valued at approximately $230,000.

Acadia Healthcare Company Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/acadia-healthcare-company-inc-achc-director-reeve-b-waud-sells-724694-shares-of-stock/1916642.html

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *